Elevated preoperative inflammatory markers based on,neutrophil-to- lymphocyteratio and C-reactive protein predict poor survival in resected non-small cell lung cancer

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3535-3538

  Tomita, Masaki ^a   Shimizu, Tetsuya ^a   Ayabe, Takanori ^a   Onitsuka, Toshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

C reactive protein; Inflammatory markers; Neutrophil to lymphocyte ratio; Non small cell lung cancer; Prognosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL COUNT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; UNIVARIATE ANALYSIS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE COUNT; MALE; NEUTROPHILS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865698629     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. O'Callaghan DS, O'Donnell D, O'Connell F and O'Byrne KJ: The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol 5: 2024-2036, 2010.
2. Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R and Mommen P: Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol 13: 1221-1230, 1995.
3. Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K and Fukushima M: Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 45: 1950-1958, 2009.
4. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P and Lim E: Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137: 425-428, 2009.
5. Tomita M, Shimizu T, Ayabe T, Yonei A and Onitsuka T: Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res 31: 2995-2998, 2011.
6. Wilop S, Crysandt M, Bendel M, Mahnken AH, Osieka R and Jost E: Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer. Onkologie 31: 665-670, 2008.
7. Koch A, Fohlin H and Sörenson S: Prognostic significance of Creactive protein and smoking in patients with advanced nonsmall cell lung cancer treated with first-line palliative chemotherapy. J Thorac Oncol 4: 326-332, 2009.
8. Hara M, Matsuzaki Y, Shimuzu T, Tomita M, Ayabe T, Enomoto Y and Onitsuka T: Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 27: 3001-3004, 2007.
9. Alifano M, Falcoz PE, Seegers V, Roche N, Schussler O, Younes M, Antonacci F, Forgez P, Dechartres A, Massard G, Damotte D and Régnard JF: Preresection serum C-reactive protein measurement and survival among patients with resectable nonsmall cell lung cancer. J Thorac Cardiovasc Surg 142: 1161-1167, 2011.
10. Tauler J and Mulshine JL: Lung cancer and inflammation: interaction of chemokines and hnRNPs. Curr Opin Pharmacol 9: 384-388, 2009.
11. Ulich TR, del Castillo J, Keys M, Granger GA and Ni RX: Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol 139: 3406-3415, 1987.
12. Ulich TR, del Castillo J, Guo K and Souza L: The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation. Am J Pathol 134: 149-159, 1989.
13. Ulich TR, del Castillo J and Guo KZ: In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. Blood 73: 108-110, 1989.
14. Heikkilä K, Ebrahim S and Lawlor DA: A systematic review of the association between circulating concentrations of C-reactive protein and cancer. J Epidemiol Community Health 61: 824-833, 2007.
15. Black S, Kushner I and Samols D: C-reactive Protein. J Biol Chem 279: 48487-48490, 2004.
16. Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS and Celli BR: C-Reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61: 23-28, 2006.